Emcure Seeks Fees After $950M Vax Trade Secrets Suit Nixed
By Caroline Simson ( December 19, 2023, 4:48 PM EST) -- Indian generic-drug maker Emcure Pharmaceuticals Ltd. is now seeking more than $3.2 million in attorney fees after convincing a Washington federal judge to toss on jurisdictional grounds Seattle-based HDT Bio Corp.'s $950 million lawsuit accusing it of stealing its COVID-19 vaccine....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.